Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

961
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
961
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

747
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

621
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
621

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Epidemiological Shifts and Trends From 2009 to 2023 in Hospital Admissions for Ruptured Aortic Aneurysms and Aortic Dissections in Austria: Retrospective, Population-Wide Study.

JMIR public health and surveillance·2026
Same author

Seasonality of Selected Cardiovascular Disorders in Austria: A Retrospective Observational Study Between 2009 and 2023.

Journal of the American Heart Association·2026
Same author

Vascular Access Management in Patients on Catheter-Based Hemodialysis.

Journal of clinical medicine·2026
Same author

Data-Driven Phenotyping Reveals Nonuniform Association Between Age and Mortality After Aortic Surgery: Retrospective Cohort Study of UK Biobank Data.

JMIR aging·2026
Same author

The Role of VEGF in Intervention-Mediated Injuries: Neointimal Hyperplasia and In-Stent Restenosis.

Journal of clinical medicine·2025
Same author

Management of dual antiplatelet therapy following covered femoropopliteal stenting - Why size matters.

VASA. Zeitschrift fur Gefasskrankheiten·2025

相关实验视频

Updated: May 5, 2026

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

13.7K

开发动脉样硬化病变的理论模型:使用跨学科洞察力的方法学方法.

Amun G Hofmann1

  • 1FIFOS-Forum for Integrative Research & Systems Biology, 1170 Vienna, Austria.

Life (Basel, Switzerland)
|August 29, 2024
PubMed
概括

本研究探讨了新的物流地图和马尔科夫模型,以了解动脉样硬化斑块动态. 这些跨学科的方法为预测心血管疾病进展提供了新的途径.

科学领域:

  • 心血管科学 心血管科学
  • 计算生物学 计算生物学
  • 随机过程 随机过程

背景情况:

  • 动脉样硬化是心血管疾病的主要原因,需要对斑块动态进行先进的建模.
  • 目前的理解需要创新的技术来预测疾病的进展和稳定性.
  • 跨学科的方法可以增强复杂的生物系统的理论建模.

研究的目的:

  • 介绍和探索两种不同的动脉样硬化斑块动态的假设模型.
  • 应用混沌理论 (逻辑地图) 和随机过程 (马尔科夫模型) 的概念.
  • 评估这些模型在理解斑块稳定性和过渡方面的潜力.

主要方法:

  • 利用混沌理论的物流地图来建模非线性斑块进展.
  • 采用各种马尔科夫模型,包括空间马尔科夫模型和马尔科夫随机场,进行概率评估.
  • 使用热图可视化空间马尔科夫模型来说明过渡概率和局部相互作用.

主要成果:

  • 后勤地图有效地捕捉了非线性进展和斑块稳定性的突然变化.
  • 马尔科夫模型为分析斑块稳定性和过渡提供了一个概率框架.
  • 空间马尔科夫模型突出了斑块发育中的局部相互作用的重要性,而马尔科夫随机场则提出了计算挑战.
关键词:
马尔科夫模型的模型动脉样硬化 动脉样硬化疾病建模 疾病建模生态学生态学是什么后勤地图 后勤地图

更多相关视频

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.3K
Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

37.2K

相关实验视频

Last Updated: May 5, 2026

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 7, 2013

13.7K
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.3K
Quantification of Atherosclerosis in Mice
06:59

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

37.2K

结论:

  • 假设的物流图和马尔科夫模型为动脉样硬化研究提供了有希望的理论框架.
  • 严格的验证与现实世界的数据至关重要,以确认这些模型的准确性和适用性.
  • 跨学科的合作对于开发心血管疾病研究中复杂的理论模型至关重要.